Telix Pharmaceuticals Limited ADR (TLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 06-2025 | 12-2024 | 06-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 141,866 | 207,156 | 439,999 | 78,385 | 81,879 |
| Receivables | 129,202 | 123,630 | 86,928 | 58,921 | 43,038 |
| Inventories | 37,080 | 35,230 | 23,620 | 20,318 | 11,501 |
| Other current assets | 22,132 | 31,997 | 19,570 | 10,746 | 18,058 |
| TOTAL | $330,280 | $398,013 | $570,117 | $168,370 | $154,476 |
| Non-Current Assets | |||||
| PPE Net | 64,412 | 42,463 | 29,899 | 20,748 | 16,713 |
| Intangibles | 0 | 584,172 | 0 | 0 | 0 |
| Other Non-Current Assets | 718,095 | 165,304 | 358,577 | 298,431 | 94,983 |
| TOTAL | $782,507 | $791,939 | $388,476 | $319,179 | $111,696 |
| Total Assets | $1,163,986 | $1,189,952 | $940,379 | $492,034 | $269,719 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 13,110 | 12,694 | 12,528 | 1,253 | 640 |
| Accounts payable and accrued liabilities | 150,349 | 133,565 | 92,310 | 55,589 | 54,284 |
| Other current liabilities | 31,875 | 92,211 | 79,772 | 89,937 | 41,616 |
| TOTAL | $231,624 | $298,582 | $205,088 | $170,423 | $109,669 |
| Non-Current Liabilities | |||||
| Long Term Debt | 391,914 | 371,478 | 341,811 | 6,564 | 5,454 |
| Other Non-Current Liabilities | 23,832 | 33,052 | 31,641 | 36,696 | 50,559 |
| TOTAL | $516,986 | $469,429 | $385,012 | $55,150 | $61,114 |
| Total Liabilities | $748,610 | $768,011 | $587,442 | $225,573 | $170,782 |
| Shareholders' Equity | |||||
| Common Shares | 479,962 | 473,110 | 393,693 | 387,454 | 296,501 |
| Retained earnings | -154,538 | -150,982 | -152,914 | -154,019 | -175,179 |
| Other shareholders' equity | 101,564 | 107,705 | 95,174 | 78,105 | 19,358 |
| TOTAL | $415,376 | $421,941 | $352,937 | $266,461 | $98,936 |
| Total Liabilities And Equity | $1,163,986 | $1,189,952 | $940,379 | $492,034 | $269,718 |